Emergence Of Extended-spectrum β-lactamase Producing Enterobacter Spp. In Patients With Bacteremia In A Tertiary Hospital In Southern Brazil

Background Extended-spectrum β-lactamases (ESBLs) are increasingly prevalent in Enterobacter spp., posing a challenge to the treatment of infections caused by this microorganism. The purpose of this retrospective study was to evaluate the prevalence, risk factors, and clinical outcomes of inpatients with bacteremia caused by ESBL and non ESBL-producing Enterobacter spp. in a tertiary hospital over the period 2004-2008. Methods The presence of blaCTX-M, blaTEM, blaSHV, and blaPER genes was detected by polymerase chain reaction (PCR) and nucleotide sequence analysis. Genetic similarity between strains was defined by pulsed-field gel electrophoresis (PFGE). Results Enterobacter spp. was identified in 205 of 4907 of the patients who had positive blood cultures during hospitalization. Of those cases, 41 (20%) were ESBL-producing Enterobacter spp. Nosocomial pneumonia was the main source of bacteremia caused by ESBL-producing Enterobacter spp. The presence of this microorganism was associated with longer hospital stays. The ESBL genes detected were: CTX-M-2 (23), CTX-M-59 (10), CTX-M-15 (1), SHV-12 (5), and PER-2 (2). While Enterobacter aerogenes strains showed mainly a clonal profile, Enterobacter cloacae strains were polyclonal. Conclusion Although no difference in clinical outcomes was observed between patients with infections by ESBL-producing and non-ESBL-producing strains, the detection of ESBL in Enterobacter spp. resulted in the change of antimicrobials in 75% of cases, having important implications in the decision-making regarding adequate antimicrobial therapy. © 2012 Elsevier España, S.L. All rights reserved.3228792Sanders, Jr.W.E., Sanders, C.C., Enterobacter spp.: Pathogens poised to flourish at the turn of the century (1997) Clin Microbiol Rev, 10, pp. 220-241Ho, P.L., Shek, R.H., Chow, K.H., Lai, W.M., Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002 (2005) J Antimicrob Chemother, 55, pp. 326-332Thomson, K.S., Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues (2010) J Clin Microbiol, 48, pp. 1019-1025Rodríguez-Baño, J., Picón, E., Gijón, P., Hernández, J.R., Cisneros, J.M., Peña, C., Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli (2010) J Clin Microbiol, 48, pp. 1726-1731Schwaber, M.J., Carmeli, Y., Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: A systematic review and meta-analysis (2007) J Antimicrob Chemother, 60, pp. 913-920Tumbarello, M., Spanu, T., Di Bidino, R., Marchetti, M., Ruggeri, M., Trecarichi, E.M., Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy (2010) Antimicrob Agents Chemother, 54, pp. 4085-4091Cheong, H.S., Ko, K.S., Kang, C.I., Chung, D.R., Peck, K.R., Song, J.H., Clinical significance of infections caused by extended-spectrum b-lactamase-producing Enterobacteriaceae Blood isolates with inducible AmpC b-lactamase (2012) Microbial Drug Resist, 18, pp. 446-452Towne, T.G., Lewis, J.S., Herrera, M., Wickes, B., Jorgensen, J.H., Detection of SHVtype extended-spectrum beta-lactamase in Enterobacter isolates (2010) J Clin Microbiol, 48, pp. 298-299(2011) Susceptibility TestingTwenty-First Informational Supplement M100-S21, , Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial CLSI, Wayne, PA, USAWoodford, N., Fagan, E.J., Ellington, M.J., Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases (2006) J Antimicrob Chemother, 57, pp. 154-155Payne, J.P., Thomson, D.J., Molecular approaches for the detection and identification of β-lactamases (1998) Molecular Bacteriology: Protocols and Clinical Applications, pp. 495-512. , N. Woodford, A.P. Johnson, Humana Press Totowa, NJ, USABauernfeind, A., Stemplinger, I., Jungwirth, R., Mangold, P., Amann, S., Akalin, E., Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase (1996) Antimicrob Agents Chemother, 40, pp. 616-620Kaufmann, M., Pulsed-field-gel-electrophoresis (1988) Molecular Bacteriology: Protocols and Clinical Applications, pp. 33-51. , N. Woodford, A.P. Johnson, Human Press NJGupta, N., Aparna, Choudhary, U., Garg, N., Arora, D.R., Enterobacter bacteremia (2003) J. Assoc Physicians India, 51, pp. 669-672Marchaim, D., Gottesman, T., Schwartz, O., Korem, M., Maor, Y., Rahav, G., National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (2010) Antimicrob Agents Chemother, 54, pp. 5099-5104Pai, H., Hong, J.Y., Byeon, J.H., Kim, Y.K., Lee, H.J., High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns (2004) Antimicrob Agents Chemother, 48, pp. 3159-3161García-Hernández, A., García-Vázquez, E., Gómez-Gómez, J., Canteras, M., Hernandez-Torres, A., Ruiz-Gomes, J., Predictor factors of ESBL versus non-ESBL Escherichia coli bacteraemia and influence of resistance on the mortality of the patients (2010) Med Clin (Barc), 136, pp. 56-60Marcos, M., Iñurrieta, A., Soriano, A., Martínez, J.A., Almela, M., Marco, F., Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp bacteraemia (2008) J Antimicrob Chemother, 62, pp. 397-403Bonnet, R., Dutour, C., Sampaio, J.L.M., Chanal, C., Sirot, D., Labia, R., Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly (2001) Antimicrob Agents Chemother, 45, pp. 2269-227